• Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Zahidova K.H., Kuliev F.A.


    About the author: Zahidova K.H., Kuliev F.A.
    Type of article Scentific article
    Annotation 84 patients with chronic heart failure of New York Heart Association (NYHA) functional class ІІ-ІV with anaemia were included in investigation. From them 54 men and 30 women. In all patients the anaemia was diagnosed at haemoglobin level (Hb) for men less than 120 г/л and in women less than 110 г/л. Reason of CHF was coronary heart disease (CHD) (postinfarction cardiosclerosis) n=40, or CHD with a diabetes mellitus (DM) 2 types n=10, with an arterial hypertension (АH) n=14, or CHD +АH+ DM n=10.Correction of anaemic syndrome at CHD with application MEB, effectively eliminates erythropoietin insufficiency, an anaemia and cytocine aggression in patients with CHF with an anaemia.
    Tags heart failure, anemic syndrome, erythropoietin, iron deficiency
    • Тепляков А.Т. Модулирующее влияние карведилола на активацию цитокинов и регресс сердечной недостаточности у больных с постинфарктной дисфункцией сердца. / А.Т. Тепляков, М.М. Дибиров [ и др.] // - Кардиология - 2004; Vol.  9: P. 50-57.
    • Gorg J. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormanal and inflammatory markers. / J.Gorg, S.Patal, D.Wexler [ et al.] //Arch Intern Med - 2005,  Jun13; Vol.  165(11). - P.1304-1309.
    • He S.W. The impact of anaemia of the prognosis chronic heart failure: a meta- analysis and systemic review / S.W. He, L.X. Wang //Congest Heart Failure - 2009; Vol.  15(3). - P. 123-130.
    • Silverberg D.S. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal functional and reduce hospitalizations . / D.S.Silverberg, D.Wexler, M. Blum, et al. // Clin. Nephrol -2003; Vol.  60(1). - P. 93-102.
    • Silverberg D.S. The effect of correction of anemia in diabetic and non diabetics with severe resistant  congestive  heart failure  and chronic renal failure by subcutaneus erythropoietin and intravenous iron.  / D.S. Silverberg, D. Wexler, M. Blum [et al.] // Nephrol Dial Transplant - 2003; Vol. 18. - P.141-146.
    • Suenivas I.M.D. Anemia in chronic heart failure: Can EPO reduce death? / I.M.D. Suenivas, T. William, M.D. Abraham //Cleveland clinic journal of medicine - 2005; Vol.  72(11), P.1027-1032.
    • Stamos T.D. Management of anaemia in heart failure  / T.D. Stamos, M.A. Silver // Curr Opin Cardiol- 2010; Vol. 25, P.148-154.
    • Silverberg D.S. Correction of iron deficiency in the cardio renal syndrome /D.S. Silverberg, D. Wexler, A. Iaing [et al.] // Int. J. Nephrol - 2011; Vol.  365. - 301 p.
    • Torre-Amione G. A study to assess the effects of a broad-spectrum  immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design / Torre- G. Amione, R. Bourge,  S.W.Colucci [et al.] //The Canadian journal of cardiology - 2007; Vol.  23(5). - P. 369-376.
    • Yankowska E.A. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. / E.A. Yankowska, P. Rozentryt, A. Witkowska [et al.] //Eur Heart J. 2010; Vol.  31(15). - P.1872-1876.
    Publication of the article «World of Medicine and Biology» №3(39) 1 part 2013 year, 107-112 pages, index UDK 616.36-005.4, 616.12-008.46